Hide metadata

dc.contributor.authorPeersen, Kari
dc.contributor.authorMunkhaugen, John
dc.contributor.authorSverre, Elise
dc.contributor.authorKristiansen, Oscar
dc.contributor.authorFagerland, Morten
dc.contributor.authorVethe, Nils T.
dc.contributor.authorPerk, Joep
dc.contributor.authorHusebye, Einar
dc.contributor.authorDammen, Toril
dc.date.accessioned2021-12-21T06:03:09Z
dc.date.available2021-12-21T06:03:09Z
dc.date.issued2021
dc.identifier.citationBMC Cardiovascular Disorders. 2021 Dec 16;21(1):596
dc.identifier.urihttp://hdl.handle.net/10852/89704
dc.description.abstractBackground To compare clinical and psychological factors among patients with self-perceived statin-associated muscle symptoms (SAMS), confirmed SAMS, and refuted SAMS in coronary heart disease patients (CHD). Methods Data were obtained from a cross-sectional study of 1100 CHD outpatients and a study of 71 CHD outpatients attending a randomized, double-blinded, placebo-controlled, crossover study to test effects of atorvastatin 40 mg/day on muscle symptom intensity. Clinical and psychosocial factors were compared between patients with and without SAMS in the cross-sectional study, and between patients with confirmed SAMS and refuted SAMS in the randomized study. Results Bilateral, symmetric muscle symptoms in the lower extremities during statin treatment were more prevalent in patients with confirmed SAMS compared to patients with refuted SAMS (75% vs. 41%, p = 0.01) in the randomized study. No significant differences in psychological factors (anxiety, depression, worry, insomnia, type D personality characteristics) were detected between patients with and without self-perceived SAMS in the cross-sectional study, or between patients with confirmed SAMS and refuted SAMS, in the randomized study. Conclusions Patients with confirmed SAMS more often present with bilateral lower muscle symptoms compared to those with refuted SAMS. Psychological factors were not associated with self-perceived SAMS or confirmed SAMS. A careful pain history and a search for alternative causes of muscle symptoms are likely to promote communication in patients with SAMS, and may reduce the risk for statin discontinuation.
dc.language.isoeng
dc.rightsThe Author(s)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleClinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects
dc.typeJournal article
dc.date.updated2021-12-21T06:03:10Z
dc.creator.authorPeersen, Kari
dc.creator.authorMunkhaugen, John
dc.creator.authorSverre, Elise
dc.creator.authorKristiansen, Oscar
dc.creator.authorFagerland, Morten
dc.creator.authorVethe, Nils T.
dc.creator.authorPerk, Joep
dc.creator.authorHusebye, Einar
dc.creator.authorDammen, Toril
dc.identifier.cristin1970863
dc.identifier.doihttps://doi.org/10.1186/s12872-021-02422-7
dc.identifier.urnURN:NBN:no-92345
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/89704/1/12872_2021_Article_2422.pdf
dc.type.versionPublishedVersion
cristin.articleid596


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International